Equity Issuances

Aptera Motors Corp issued up to an aggregate of 135,000 shares of Common Stock of warrant to A.G.P./Alliance Global Partners.

“the Company issued to the Placement Agent warrants (the " Placement Agent Warrants ") to purchase up to an aggregate of 135,000 shares of Common Stock (the " Placement Agent Warrant Shares ") at an exercise price equal to $2.10 per share.”

BlackRock Private Credit Fund issued 1,107,769.423 of common stock to feeder vehicles for $26,532,074.68.

“of the Fund. Date of Unregistered Sale Amount of Institutional Class Shares Sold Consideration January 2, 2026 (number of shares finalized on January 21, 2026) 1,107,769.423 $26,532,074.68”

VISTA CREDIT STRATEGIC LENDING CORP. issued 10,004,903.613 shares of Class I common stock; 6,327.954 shares of Class S common stock as of December 31, 2025; and 1,143,056.311 shares of Class I common stoc of common stock to accredited investors and non-U.S. persons for $191,008,064 (December 31, 2025) and $22,579,500 (January 2, 2026).

“As of December 31, 2025 and January 2, 2026, Vista Credit Strategic Lending Corp. (the “Company”) sold shares of the Company ’ s Class I and Class S common stock (together with the Company's Class D common stock, the “Common Stock”).”

USA Rare Earth, Inc. issued warrants initially exercisable to purchase common stock at $12.00 per share and currently exercisable to purchase common stock at $7.00 per share of warrant to holders of the Existing Warrants for amendment provided that any Government Financing is an 'Exempt Issuance' and will not result in any adjustment of the Exercise Price.

“the Company entered into amendments (the " Warrant Amendments ") with each holder of the Company’s warrants initially exercisable to purchase common stock at $12.00 per share and currently exercisable to purchase common stock at $7.00 per share, subject to adjustment, initially exercisable on March 13, 2025 (the " Existing Warrants ") to provide that any Government Financing is an "Exempt Issuance" (as defined in the respective Warrant Amendments) and therefore will not result in any adjustment of the Exercise Price (as defined in the respective Existing Warrants).”

Apollo Infrastructure Co LLC issued 181,149 Series I A-II Shares, 115,275 F-I Shares, 879 E Shares, 94,132 I Shares, 1,074,575 Series II A-II Shares, 13,384 F-I Shares, 31,606 I Shares of preferred stock to third party investors for $5,082,940, $3,186,850, $25,000, $2,605,000, $30,564,027, $375,000, $887,500.

“As of January 2, 2026, Apollo Infrastructure Company LLC (the “Company”) issued and sold the following unregistered shares of the Company (with the final number of shares being determined on January 26, 2026) to third party investors for cash: Type Number of Shares Sold Aggregate Consideration Series I A-II Shares* 181,149 $ 5,082,940 F-I Shares 115,275 3,186,850 E Shares 879 25,000 I Shares 94,132 2,605,000 Series II A-II Shares 1,074,575 $ 30,564,027 F-I Shares 13,384 375,000 I Shares 31,606 887,500”

XCF Global, Inc. issued 7,000,000 million shares of common stock to EEME Energy SPV I LLC for $700,000.

“Contemporaneously with the execution of this Term Sheet, EEME is expected to purchase 7,000,000 million shares of Common Stock for $700,000.”

New Mountain Private Credit Fund issued 60,141 of common stock to unknown for approximately $1.4 million at a price per Share equal to $24.06.

“In connection with the continuous private offering (the “Private Offering”) of New Mountain Private Credit Fund, a Maryland statutory trust (the “Company”), as of January 2, 2026 , the Company sold an aggregate of 60,141 of its common shares of beneficial interest for the month of January (the “Shares”), for aggregate consideration of approximately $1.4 million at a price per Share equal to $24.06 (with the final number of shares being determined on January 26, 2026 ).”

WhiteFiber, Inc. issued up to 11,318,898 Ordinary Shares of convertible note to initial purchasers for $230.0 million aggregate principal amount.

“Definitive Agreement. Indenture and Notes On January 26, 2026, WhiteFiber, Inc. (the “ Company ”) completed its previously announced private offering (the “ Offering ”) of $230.0 million aggregate principal amount of its 4.500% Convertible Senior Notes due 2031 (the “ Notes ”), including the exercise in full of the initial purchasers’ option to purchase an”

XCel Brands, Inc. issued common stock to White Lion Capital, LLC.

“On January 21, 2026 (the “Execution Date”), Xcel Brands, Inc. (the “Company”) entered into a common stock purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”), with White Lion Capital, LLC (the “Investor”), pursuant to which the Investor has committed to purchase up to $15.0 million of the Company’s common stock, par value $0.001 per share (the “Common Stock”), subject to certain limitations and satisfaction of the conditions set forth in the Purchase Agreement.”

Vivakor, Inc. issued 9,215,789 shares of the Company’s common stock of common stock to two non-affiliated accredited investors for converting a total of $41,165 of the amounts due.

“On January 16, 2026, the Company received Notices of Conversion from two of the Lenders converting a total of $41,165 of the amounts due under the Lender Notes into 9,215,789 shares of the Company’s common stock”

Two Hands Corp issued convertible note to Vanquish Funding Group LLC for purchase price of $87,000.

“Vanquish ”), pursuant to which the Company sold and Vanquish purchased a convertible promissory note in the principal amount of $100,050 (the “ Note ”), for a purchase price of $87,000 (the “ Transaction ”). The Transaction closed on or about January 20, 2026, Vanquish’s legal expenses of $2,500 were paid from the purchase price, $4,500 was retained by Vanquish”

Jaguar Health, Inc. issued 2,870,503 shares of warrant to Iliad Research and Trading, L.P. for 87.78 shares of Series M Preferred Stock.

“pursuant to which the Company issued a pre-funded common stock purchase warrant to purchase 2,870,503 shares of Common Stock (the "Fifth Pre-Funded Warrant") to Iliad in exchange for 87.78 shares of Series M Preferred Stock held by Iliad.”

Jaguar Health, Inc. issued 3,249,908 shares of warrant to Streeterville Capital, LLC for 99.3822 shares of Series L Preferred Stock.

“pursuant to which the Company issued a pre-funded common stock purchase warrant to purchase 3,249,908 shares of Common Stock (the "Fourth Pre-Funded Warrant") to Streeterville in exchange for 99.3822 shares of Series L Preferred Stock held by Streeterville.”

Jaguar Health, Inc. issued 719,424 shares of warrant to Iliad Research and Trading, L.P. for 22 shares of Series L Preferred Stock.

“pursuant to which the Company issued a pre-funded common stock purchase warrant to purchase 719,424 shares of Common Stock (the "Third Pre-Funded Warrant") to Iliad in exchange for 22 shares of Series L Preferred Stock held by Iliad.”

Jaguar Health, Inc. issued 1,111,837 shares of warrant to Streeterville Capital, LLC for $850,000 reduction in the outstanding balance of the August 2022 Royalty Interest.

“with Streeterville. Pursuant to this agreement, the Company issued a pre-funded common stock purchase warrant to purchase 1,111,837 shares of Common Stock (the "Second Pre-Funded Warrant") to Streeterville in exchange for a $850,000 reduction in the outstanding balance of the August 2022 Royalty Interest.”

Jaguar Health, Inc. issued 1,553,844 shares of warrant to Iliad Research and Trading, L.P. for $1,187,914.07 reduction in the outstanding balance of the October 2020 Royalty Interest.

“with Iliad. Pursuant to this agreement, the Company issued a pre-funded common stock purchase warrant to purchase 1,553,844 shares of Common Stock (the "First Pre-Funded Warrant") to Iliad in exchange for a $1,187,914.07 reduction in the outstanding balance of the October 2020 Royalty Interest.”

Ondas Inc. issued 303,250 shares of Preferred Stock of preferred stock to Charles & Potomac Capital, LLC for $27.70 per share.

“Pursuant to the Networks Agreement, the Purchasers would acquire the following in the Networks Offering for gross proceeds to Networks of $8.4 million, which included approximately $6.0 million from the Company and approximately $2.0 from C&P, as Purchasers: (i) 303,250 shares of Preferred Stock (the “Purchased Preferred Stock”), at a purchase price of $27.70 per share”

Interactive Strength, Inc. issued 2,110,901 shares of Common Stock of convertible note to TR Opportunities II LLC for reduction of $1,574,867 of principal amount of Incremental Note.

“On January 16, 2026, the Current Holder delivered several notices of conversion to convert $[1,574,867] of the principal amount of the Incremental Note into a total of 2,110,901 shares of Common Stock (the “Conversion Shares”).”

Blackstone Private Credit Fund issued 10,162,444 of common stock for $ 251,926,982.

“Date of Unregistered Sale Amount of Class I Common Shares Consideration As of January 1, 2026 (number of shares finalized on January 22, 2026) 10,162,444 $ 251,926,982”

Apollo Debt Solutions BDC issued 1,832,227 of common stock to feeder vehicles primarily created to hold the Fund's Class I Common Shares for $44,714,776.

“Date of Unregistered Sale Amount of Class I Common Shares Consideration As of January 2, 2026 (number of shares finalized on January 23, 2026) 1,832,227 $ 44,714,776”

LanzaTech Global, Inc. issued preferred stock to LanzaTech Global SPV, LLC for mandatory conversion and elimination of redemption provisions.

“the Company filed a Second Amended and Restated Certificate of Designation of Series A Convertible Senior Preferred Stock”

LanzaTech Global, Inc. issued warrant to purchase 7,800,000 shares of Common Stock of warrant to LanzaTech Global SPV, LLC for exercise price equal to $0.0000001 per share.

“and new institutional investors (the “Investors”), pursuant to which the Investors purchased, in private placements, shares (the “Subscribed Shares”) of common stock, par value $0.0000001 per share (“Common Stock”), of the Company, for cash. Pursuant to the Subscription Agreements, on the Closing Date, the Company issued and sold a total of 4,000,000 Subscribed”

LanzaTech Global, Inc. issued 3,250,322 shares of Common Stock of common stock to LanzaTech Global SPV, LLC for mandatory conversion of preferred stock.

“all outstanding shares of the Preferred Stock were automatically converted into the Conversion Shares as of the Closing Date”

LanzaTech Global, Inc. issued 4,000,000 Subscribed Shares and 510,968 Bonus Shares of common stock to certain existing and new institutional investors for $5.00 per share, $20,000,000 aggregate gross proceeds.

“the Company issued and sold a total of 4,000,000 Subscribed Shares to the Investors at a per share purchase price of $5.00”

QT IMAGING HOLDINGS, INC. issued up to an additional 48,214 shares of Common Stock of warrant to Dr. Avi Katz for $6.43 per share exercise price.

“of Common Stock (all of such shares issuable upon exercise of the January 2026 Warrant, the “ January 2026 Warrant Shares ”). The purchase price of each January 2026 Share is $6.43, which represents 110% of the 5-day volume weighted trading price for the Common Stock on January 22, 2026 (the “ January 2026 Per Share Purchase Price ”), and the per share”

QT IMAGING HOLDINGS, INC. issued 24,107 shares of common stock to Dr. Avi Katz for $6.43 per share.

“of Common Stock (all of such shares issuable upon exercise of the January 2026 Warrant, the “ January 2026 Warrant Shares ”). The purchase price of each January 2026 Share is $6.43, which represents 110% of the 5-day volume weighted trading price for the Common Stock on January 22, 2026 (the “ January 2026 Per Share Purchase Price ”), and the per share”

C2 Blockchain, Inc. issued 50,000,000 restricted shares of common stock to Mendel Holdings, LLC for services rendered.

“On January 21, 2026, pursuant to a unanimous written consent of the Company’s Board of Directors, C2 Blockchain, Inc. (the “Company”) issued 50,000,000 restricted shares of common stock to Mendel Holdings, LLC”

First Eagle Private Credit Fund issued 297 of common stock to a feeder vehicle primarily created to hold the Fund’s common shares for $7,200.

“details the shares sold: Date of Unregistered Sale Amount of Class I Common Shares Consideration As of January 1, 2026 (number of shares finalized on January 23, 2026) 297 $ 7,200”

ASPAC III Acquisition Corp. issued 1,499,900 Class B ordinary shares of common stock to A SPAC III (Holdings) Corp. (Sponsor) for 1,499,900 Class A ordinary shares.

“Pursuant to the Exchange Agreement between A SPAC III Acquisition Corp. (“the Company”) and A SPAC III (Holdings) Corp. (the “Sponsor”), dated January 16, 2026, the Sponsor has transferred and delivered to the Company 1,499,900 Class B ordinary shares of the Company (the “Class B Shares”) in exchange for 1,499,900 Class A ordinary shares of the Company (the “Class A Shares”) (the “Share Exchange”).”

Goldman Sachs Private Credit Corp. issued 12,358,659 of common stock to accredited investors and/or Non-U.S. Person for $308,842,901.

“The following table details the Shares sold: Date of Unregistered Sale Amount of Class I Shares Consideration As of January 1, 2026 (number of shares finalized on January 23, 2026) 12,358,659 $308,842,901”

Blackstone Private Real Estate Credit & Income Fund issued 1,917,913 of common stock to participating investors for $50,000,000.

“the Common Shares sold: Date of Unregistered Sale Amount of Common Shares Consideration As of January 1, 2026 (number of Common Shares finalized on January 22, 2026) 1,917,913 $50,000,000 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto”

Collab Z Inc. issued up to 1,250,000 shares of preferred stock to accredited investors for $4.00 per share.

“the Company offered and sold up to 1,250,000 shares of its newly created Series C at a price of $4.00 per share to the Investors pursuant to the Securities Purchase Agreement”

FG Imperii Acquisition Corp. issued 1,000,000 warrants of warrant to FG Imperii Investors LLC for $100,000.

“(ii) the private placement of an aggregate of 1,000,000 warrants (“OTM Warrants” and, together with the Private Placement Units, the “Private Placement Securities”) at a price of $0.10 per warrant, each exercisable to purchase one share of Class A common stock at $15.00 per share, for an aggregate purchase price of $100,000”

QHSLab, Inc. issued 1,568,432 shares of common stock to MedScience Research Group, Inc. for cancellation of indebtedness.

“the Company issued an aggregate of 1,568,432 shares of its common stock, par value $0.0001 per share (the “Shares”), as directed by MedScience”

ProPhase Labs, Inc. issued up to 240,369 shares of common stock of warrant to Generating Alpha Ltd..

“In connection with entering into the Agreement, the Company issued 549,105 shares of common stock and a prefunded common stock purchase warrant to acquire up to 240,369 shares of common stock as a commitment fee.”

ProPhase Labs, Inc. issued 549,105 shares of common stock to Generating Alpha Ltd..

“In connection with entering into the Agreement, the Company issued 549,105 shares of common stock and a prefunded common stock purchase warrant to acquire up to 240,369 shares of common stock as a commitment fee.”

Larimar Therapeutics, Inc. issued 250,000 shares of Series A convertible preferred stock of preferred stock to Blue Owl Healthcare Opportunities IV Public Investments LP for 2,500,000 shares of common stock.

“On January 21, 2026, Larimar Therapeutics, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Blue Owl Healthcare Opportunities IV Public Investments LP (the “Stockholder”), pursuant to which the Stockholder exchanged 2,500,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for 250,000 shares of Series A convertible preferred stock, a “toothless” preferred stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) (the “Exchange”).”

Globaltek Ventures, Inc. issued 1-for-1200 reverse stock split of common stock.

“On January 20, 2026 ATVK, Inc. (the “Company”) effected a 1-for-1200 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock.”

EKSO BIONICS HOLDINGS, INC. issued up to an aggregate of 355,960 shares of Common Stock of warrant to certain institutional and accredited investors for exercise price of $8.22 per share.

“warrants (the “Warrants”) to purchase up to an aggregate of 355,960 shares of Common Stock at an exercise price of $8.22 per share of Common Stock”

EKSO BIONICS HOLDINGS, INC. issued 5,852 shares of the Company's newly designated Series B Convertible Preferred Stock of preferred stock to certain institutional and accredited investors for stated value of $1,000 per share.

“On January 20, 2026, Ekso Bionics Holdings, Inc. (the “Company”) entered into securities purchase agreements (collectively, the “Purchase Agreements”) with certain institutional and accredited investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Private Placement”), (i) an aggregate of 5,852 shares of the Company’s newly designated Series B Convertible Preferred Stock, with a par value $0.001 per share and stated value (the “Stated Value”) of $1,000 per share (the “Series B Preferred Stock”)”

AMERICAN REBEL HOLDINGS INC issued 382,000 shares of Common Stock of common stock to Silverback Capital Corporation for payment of approximately $125,257.80.

“On January 20, 2026, SCC requested the issuance of 382,000 shares of Common Stock to SCC, representing a payment of approximately $125,257.80.”

AMERICAN REBEL HOLDINGS INC issued 157,330 shares of common stock of common stock to 1800 Diagonal Lending LLC for $59,581 remaining principal amount converted.

“On the same day, 1800 Diagonal Lending LLC converted the remaining $59,581 of the amount owed under the July 7, 2025 promissory note into 157,330 shares of common stock.”

AMERICAN REBEL HOLDINGS INC issued 132,031 shares of common stock of common stock to 1800 Diagonal Lending LLC for $50,000 principal amount converted.

“On January 16, 2026, 1800 Diagonal Lending LLC converted $50,000 of the principal amount owed under the July 7, 2025 promissory note into 132,031 shares of common stock.”

AMERICAN REBEL HOLDINGS INC issued 351,789 shares of common stock of common stock to Streeterville Capital, LLC for exchange of $115,000 Partitioned Note.

“the principal amount of $5,470,000. Pursuant to the Exchange, the Company and Streeterville agreed to partition a new Secured Promissory Note in the original principal amount of $115,000.00 (the “Partitioned Note”) from the Note and then cause the outstanding balance of the Note to be reduced by an amount equal to the initial outstanding balance of the Partitioned”

AMERICAN REBEL HOLDINGS INC issued 100,000 shares of common stock of common stock to 1800 Diagonal Lending LLC for $38,250 principal amount converted.

“On January 15, 2026, 1800 Diagonal Lending LLC converted $38,250 of the principal amount owed under the July 7, 2025 promissory note into 100,000 shares of common stock.”

AMERICAN REBEL HOLDINGS INC issued 133,333 shares of common stock of common stock to 1800 Diagonal Lending LLC for $60,000 principal amount converted.

“On January 14, 2026, 1800 Diagonal Lending LLC converted $60,000 of the principal amount owed under the July 7, 2025 promissory note into 133,333 shares of common stock.”

Crypto Co issued 90,000,000 shares of common stock to White Dwarf LLC, Ryan Crownholm, and Scott Averitt for $100,000.

“Beginning on January 15, 2026, The Crypto Company (the “ Company ”) executed Subscription Agreements (each, a “ Subscription Agreement ” and collectively, the “ Subscription Agreements ”) with certain institutional and other accredited investors: White Dwarf LLC, Ryan Crownholm, and Scott Averitt (each, an “ Investor ” and collectively, the “ Investors ”), pursuant to which the Company agreed to sell and issue to the Investors an aggregate of 90,000,000 shares of the Company’s common stock, par value $0.001 (“ Common Stock ”) for an aggregate purchase price of $100,000.”

Monroe Capital Income Plus Corp issued 4,690,159 shares of its common stock of common stock to each investor in the registrant for $9.87 per share.

“On January 2, 2026, Monroe Capital Income Plus Corporation (the "Company") issued an aggregate of 4,690,159 shares of its common stock, par value $0.01 per share (the “Common Stock”), at a price per share of $9.87 (with the final number of shares being determined on January 22, 2026), for an aggregate offering price of $46,291,871.”

Barings Private Credit Corp issued 5,098,618.965* unregistered shares of common stock to participating investors for aggregate consideration of approximately $103.9 million.

“As of January 2, 2026, Barings Private Credit Corporation (the “Company”) sold 5,098,618.965* unregistered shares (the “Sold Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (with the number of Sold Shares issued being determined on January 21, 2026) pursuant to subscription agreements entered into with the participating investors for aggregate consideration of approximately $103.9 million.”

CDT Equity Inc. issued 204,031 shares of common stock to an institutional investor.

“the Company agreed to issue 204,031 shares of Common Stock to the Purchaser (the “Commitment Shares”).”